Lupin files Spiriva in US and Enbrel in EU

Lupin has realised plans to file an abbreviated new drug application (ANDA) for generic Spiriva (tiotropium bromide) in the US, as the Indian firm continues to advance its pipeline of complex generics, including respiratory drugs, and biosimilars.

Lupin has realised plans to file an abbreviated new drug application (ANDA) for generic Spiriva (tiotropium bromide) in the US, as the Indian firm continues to advance its pipeline of complex generics, including respiratory drugs, and biosimilars.

The US Food and Drug Administration (FDA) filing comes after Lupin completed a pharmacodynamic study for its generic of Boehringer...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business